TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2409543

Group type: EXPERIMENTAL
Intervention: Flecainide acetate (200 mg twice daily)
Number of subjects: 14
Study: 29063186

Group type: EXPERIMENTAL
Intervention: Rice bran (n=35)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Rice husk powder (n=35)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (n=35)
Number of subjects: 105
Study: 27852545

Group type: EXPERIMENTAL
Intervention: Synbiotic preparation containing Lactobacillus casei, L. plantarum, L. rhamnosus, Bifidobacterium lactis and prebiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc suspension (15 mg/day for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (ORS and/or intravenous therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synbiotic group
Number of subjects: 0
Study: 24811326

Group type: EXPERIMENTAL
Intervention: Personal Calorie Monitor (PCM) in thermoneutral conditions
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Personal Calorie Monitor (PCM) in cool conditions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Indirect calorimetry (IC) in thermoneutral conditions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Indirect calorimetry (IC) in cool conditions
Number of subjects: 34
Study: 23242727

Group type: EXPERIMENTAL
Intervention: Hydrocortisone ointment
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Hydrocortisone + mupirocin ointment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Emollient ointment
Number of subjects: 83
Study: 20213468

Group type: EXPERIMENTAL
Intervention: Isokinetic training (IT) at 80 rpm
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Weight training (WT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both groups (WT and IT)
Number of subjects: 18
Study: 18798830

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) intravenous (i.v.)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Phenytoin (PHT) intravenous (i.v.)
Number of subjects: 74
Study: 15849424

Group type: EXPERIMENTAL
Intervention: Apple polyphenol (Ap) 500 mg once daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11831005

Group type: EXPERIMENTAL
Intervention: ecabet sodium
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: rebamipide
Number of subjects: 21
Study: 10428581

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 25
Study: 7745785

Group type: EXPERIMENTAL
Intervention: General anesthesia plus epidural anesthesia (bupivacaine 0.25% with 200,000 epinephrine, 0.75 ml.kg‐1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: General anesthesia plus epidural anesthesia
Number of subjects: 21
Study: 1975198

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enprofylline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7010929

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1200 mg daily for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31479722

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg subcutaneously, administered in-hospital and after 4 weeks, on top of atorvastatin 40 mg.
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo, administered in-hospital and after 4 weeks, on top of atorvastatin 40 mg.
Number of subjects: 308
Study: 28689179

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 3956

Group type: COMPARATOR
Intervention: Edoxaban
Number of subjects: 3956
Study: 27901619

Group type: EXPERIMENTAL
Intervention: Brøset Violence Checklist (BVC) implemented in 7 intervention wards
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control wards (8 wards without BVC)
Number of subjects: 15
Study: 24433264

Group type: EXPERIMENTAL
Intervention: Intracutaneous suture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transcutaneous skin stapling
Number of subjects: 0
Study: 20574648

Group type: EXPERIMENTAL
Intervention: Tocilizumab monotherapy
Number of subjects: 302

Group type: COMPARATOR
Intervention: DMARDs
Number of subjects: 302
Study: 20101919

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 27
Study: 17201546

Group type: EXPERIMENTAL
Intervention: Exposure to a physically attractive target
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Body dissatisfaction
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exposure to attractive models and nonmodels
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exposure to a thin vase
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Manipulation of body dissatisfaction
Number of subjects: 6
Study: 15073451

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (Crestor) 5-40 mg
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (Crestor) > or =96 weeks
Number of subjects: 10000
Study: 11284474

Group type: COMPARATOR
Intervention: Current protocol (gastric residual volume threshold, 150 mL, optional prokinetic)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Proposed feeding protocol (gastric residual volume threshold 250 mL, mandatory prokinetic)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Proposed feeding protocol
Number of subjects: 96

Group type: COMPARATOR
Intervention: Current protocol
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 96
Study: 9396172

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori positive patients
Number of subjects: 92

Group type: COMPARATOR
Intervention: Helicobacter pylori negative patients
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Patients with normal mucosa
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Patients younger than fifty
Number of subjects: 92
Study: 7701793

Group type: EXPERIMENTAL
Intervention: Elevated blood gastrin levels in colorectal cancer patients
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Hypergastrinemia incidence
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Gastrin concentration in elderly patients
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Preoperative gastrinemia levels
Number of subjects: 112
Study: 3548735

Group type: EXPERIMENTAL
Intervention: Fish oil supplement (MaxEPA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 60
Study: 29624537

Group type: EXPERIMENTAL
Intervention: Intravascular temperature management
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Conventional cooling plus intravascular temperature management
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional cooling
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Conventional cooling and intravascular temperature management
Number of subjects: 21
Study: 26725762

Group type: EXPERIMENTAL
Intervention: losartan/HCTZ
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: CCB/ARB
Number of subjects: 231
Study: 24868151

Group type: EXPERIMENTAL
Intervention: Comorbidity-adapted exercise protocols for physiological adaptations (coronary disease, heart failure, hypertension, diabetes type 2, chronic obstructive pulmonary diseases, obesity)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Comorbidity-adapted exercise protocols for behavioral adaptations (chronic a-specific pain, nonspecific low back pain, depression)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Comorbidity-adapted exercise protocols for environmental adaptations (visual or hearing impairments)
Number of subjects: 11
Study: 23793042

Group type: EXPERIMENTAL
Intervention: Smoking a virtual cigarette
Number of subjects: 45

Group type: COMPARATOR
Intervention: Throwing virtual darts
Number of subjects: 45

Group type: COMPARATOR
Intervention: Just being in the virtual pub
Number of subjects: 45
Study: 21059184

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BMI)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Computer-delivered interventions (CDIs)
Number of subjects: 677

Group type: COMPARATOR
Intervention: Control (delayed control)
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: All interventions (BMI and CDIs)
Number of subjects: 677
Study: 17700653

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) for predicting total body water (TBW)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) for predicting fat‐free mass (FFM)
Number of subjects: 341
Study: 17136944

Group type: EXPERIMENTAL
Intervention: Creatine plus beta-alanine (CA)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Creatine (C)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 33
Study: 12712108

Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg (twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg (twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nimesulide 200 mg (twice daily)
Number of subjects: 30
Study: 10724053

Group type: EXPERIMENTAL
Intervention: Pyuria with a white blood cell count greater than 10 per microliter
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Mean urine leukocyte count in patients with CAUTI
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Pyuria associated with CAUTI caused by gram-negative bacilli
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Pyuria associated with infections caused by coagulase-negative staphylococci and enterococci
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Pyuria associated with infections caused by yeasts
Number of subjects: 761
Study: 8923079

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 15

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Responders (n = 9)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nonresponders (n = 6)
Number of subjects: 15
Study: 1414899

Group type: EXPERIMENTAL
Intervention: Amiodarone (400 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mexiletine (720 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Overall patient group
Number of subjects: 22
Study: 3926135

Group type: EXPERIMENTAL
Intervention: Magnesium aspartate (15 mmol magnesium/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31310277

Group type: EXPERIMENTAL
Intervention: Intravenous Acetaminophen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29940292

Group type: EXPERIMENTAL
Intervention: ITACA smoking prevention education program (4-year cognitive-behavioral intervention based on the social-influences model integrated into schools' regular curricular activities)
Number of subjects: 1055
Study: 27670863

Group type: EXPERIMENTAL
Intervention: Therapeutic aerobic exercise with music therapy (G1)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Therapeutic aerobic exercise at any rhythm (G2)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 35
Study: 25447467

Group type: EXPERIMENTAL
Intervention: Tobacco Tactics website with nurse counseling by phone and access to nicotine replacement therapy (NRT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: 1-800-QUIT-NOW telephone line intervention
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Tobacco Tactics website
Number of subjects: 145
Study: 22344198

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 11.25 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 30 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Leuprolide acetate depot (both doses)
Number of subjects: 84
Study: 20668455

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day; n=15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (n=16)
Number of subjects: 31
Study: 17436360

Group type: EXPERIMENTAL
Intervention: Xiong‐gui‐tiao‐xue‐yin at a dose of 6.0 g/day (Group X)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Ergometrine (methylergometrine maleate) at a dose of 0.375 mg/day (Group E)
Number of subjects: 82
Study: 15464183

Group type: COMPARATOR
Intervention: No further chemotherapy (n=200)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy (n=210)
Number of subjects: 410
Study: 11451592

Group type: EXPERIMENTAL
Intervention: Composite skin replacement (CSR)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Split thickness autograft (Control)
Number of subjects: 7
Study: 9680921

Group type: EXPERIMENTAL
Intervention: Gel
Number of subjects: 25

Group type: COMPARATOR
Intervention: Margarine
Number of subjects: 25
Study: 8003844

Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate (APD) 30 mg as a single infusion every 3 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral fluoride (20‐30 mg F/day)
Number of subjects: 32
Study: 2571403

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) aqueous nasal spray
Number of subjects: 18

Group type: COMPARATOR
Intervention: Terfenadine tablets
Number of subjects: 18
Study: 1105726

Group type: EXPERIMENTAL
Intervention: New method for objective assessment of cough
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Double blind crossover trial
Number of subjects: 18
Study: 31802129

Group type: EXPERIMENTAL
Intervention: Insomnia symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oversleeping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Undersleeping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous sleep duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronotype
Number of subjects: 0
Study: 29697450

Group type: EXPERIMENTAL
Intervention: Regression Modeling (RM)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Historical Mean (HM)
Number of subjects: 207
Study: 28880972

Group type: EXPERIMENTAL
Intervention: MVA-5T4
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combination of MVA-5T4 and cyclophosphamide
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 55

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 55
Study: 26296452

Group type: EXPERIMENTAL
Intervention: Low energy diet (LED, 800‐1,000 kcal/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aerobic interval training (AIT)
Number of subjects: 70
Study: 23844569

Group type: EXPERIMENTAL
Intervention: Diabetes Interactive Diary (DID)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Traditional education (Control)
Number of subjects: 127
Study: 21828301

Group type: EXPERIMENTAL
Intervention: Questioning during lectures (experimental lectures with questions asked throughout)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Traditional lecturing methods (control lectures)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Questioning during lectures
Number of subjects: 23
Study: 19576065

Group type: EXPERIMENTAL
Intervention: Group A: traditional superior corneal incision phacoemulsification surgery and AcrySof SN60AT IOL implantation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group B: corneal topography guiding incision phacoemulsification surgery and AcrySof SN60AT IOL implantation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group C: corneal topography guiding incision phacoemulsification surgery and AcrySof SN60WF IOL implantation
Number of subjects: 90
Study: 17094524

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg cisatracurium [2ED95]
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.6 mg rocuronium [2ED95]
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of 0.075 mg/kg cisatracurium [1ED95] plus 0.3 mg rocuronium [1ED95]
Number of subjects: 60
Study: 16242695

Group type: EXPERIMENTAL
Intervention: Pubovaginal sling
Number of subjects: 92

Group type: COMPARATOR
Intervention: Tension-free vaginal tape
Number of subjects: 92

Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 92
Study: 12138980

Group type: EXPERIMENTAL
Intervention: 2% alcoholic chlorhexidine gluconate
Number of subjects: 215

Group type: COMPARATOR
Intervention: 2% alcoholic tincture of iodine
Number of subjects: 215
Study: 9921571

Group type: EXPERIMENTAL
Intervention: One injection of 1.6 ml (480 mcg) of G-CSF
Number of subjects: 76

Group type: COMPARATOR
Intervention: Two injections of 0.8 ml each of G-CSF
Number of subjects: 76
Study: 7476576

Group type: EXPERIMENTAL
Intervention: Monoionic contrast medium (sodium/‐meglumine ioxaglate, Hexabrix)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-ionic contrast medium (iopromide, Ultravist 300)
Number of subjects: 20
Study: 2280237

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 11

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 11
Study: 574098

Group type: EXPERIMENTAL
Intervention: Metformin (1.7 g/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Clofibrate (2 g/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined therapy (Metformin + Clofibrate)
Number of subjects: 22
Study: 31735410

Group type: EXPERIMENTAL
Intervention: Acute-phase cognitive therapy (A-CT)
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Continuation-phase treatment (CCT)
Number of subjects: 764

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 764

Group type: COMPARATOR
Intervention: Matched pill placebo
Number of subjects: 764
Study: 31153781

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone (HC) 100mg every eight hours until the second postoperative day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27916987

Group type: EXPERIMENTAL
Intervention: 5-week very-low-calorie diet (500 kcal per day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 12-week low-calorie diet (1250 kcal per day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Weight stable diet (WS period)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Weight loss (WL) period
Number of subjects: 61
Study: 26529011

Group type: EXPERIMENTAL
Intervention: Multi-Vitamin/Mineral (MVM) supplementation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 23363495

Group type: EXPERIMENTAL
Intervention: Fractional dose of IPV (one fifth of a full dose) administered intradermally
Number of subjects: 310

Group type: COMPARATOR
Intervention: Full dose of IPV administered intramuscularly
Number of subjects: 310
Study: 21208748

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 19954721

Group type: EXPERIMENTAL
Intervention: HFR (Hemodiafiltration with on-line endogenous reinfusion)
Number of subjects: 11

Group type: COMPARATOR
Intervention: LHD (Conventional low flux hemodialysis)
Number of subjects: 11
Study: 17359208

Group type: EXPERIMENTAL
Intervention: General anaesthesia for dental extraction
Number of subjects: 201
Study: 14722327

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day for 3 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: MDMA (100 mg)
Number of subjects: 12
Study: 11476796

Group type: EXPERIMENTAL
Intervention: Subcutaneous hCG (5,000 IU)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intramuscular hCG (5,000 IU)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both subcutaneous and intramuscular hCG
Number of subjects: 28
Study: 9570254

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin (750 mg b.d.)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intravenous cephazolin (1 g b.d.)
Number of subjects: 150
Study: 8047707

Group type: EXPERIMENTAL
Intervention: Rockport Fitness Walking Test (RFWT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New prediction equations derived from RFWT variables
Number of subjects: 0

Group type: COMPARATOR
Intervention: Kline, Porcari, Hintermeister equations (1987)
Number of subjects: 0
Study: 2925842

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine A + Prednisone (CsA + P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) and Cyclosporine A + Prednisone (CsA + P)
Number of subjects: 0
Study: 804159

Group type: EXPERIMENTAL
Intervention: Clindamycin hydrochloride
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 244

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin
Number of subjects: 244
Study: 31216196

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced CT
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (aged-matched male outpatients)
Number of subjects: 200
Study: 27836205

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate microbial sealant (CMS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard skin preparation without CMS
Number of subjects: 300
Study: 26320917

Group type: EXPERIMENTAL
Intervention: Non-English speaking Hispanics
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: English-speaking Asians
Number of subjects: 933

Group type: EXPERIMENTAL
Intervention: Non-English speaking Asians
Number of subjects: 933
Study: 22956434

Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (TAC) plus prednisone for 12 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Prednisone combined with intravenous cyclophosphamide (CYC) for 24 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (TAC) plus prednisone
Number of subjects: 56
Study: 22111446

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Midazolam/Fentanyl
Number of subjects: 41
Study: 19700774

Group type: EXPERIMENTAL
Intervention: Low-dose oral enoximone
Number of subjects: 1854

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1854
Study: 17145722

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 19257

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily (Amlodipine-based regimen)
Number of subjects: 19257

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily (Atenolol-based regimen)
Number of subjects: 19257

Group type: COMPARATOR
Intervention: Placebo (Amlodipine-based regimen)
Number of subjects: 19257

Group type: COMPARATOR
Intervention: Placebo (Atenolol-based regimen)
Number of subjects: 19257